Author [ Title(Desc)] Type Year
Filters: First Letter Of Title is G  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Dierselhuis MP, Spierings E, Brand R, Hendriks M, Canossi A, Dolstra H, Eliaou J-F, Enczmann J, Gervais T, Kircher B, et al. Gender influences the birth order effect in HLA-identical stem cell transplantation. Blood. 2013;121(23):4809-11.
Rodrigues EMillicent, Ardissino G, Pintarelli G, Capone V, Mariotti J, Verna M, Bernardo MEster, Faraci M, Tozzi M, Bucalossi A, et al. Gene Abnormalities in Transplant Associated-Thrombotic Microangiopathy: Comparison between Recipient and Donor's DNA. Thromb Haemost. 2021.
Liang Y, Xu H, Cheng T, Fu Y, Huang H, Qian W, Wang J, Zhou Y, Qian P, Yin Y, et al. Gene activation guided by nascent RNA-bound transcription factors. Nat Commun. 2022;13(1):7329.
Kwiatkowski JL. Gene addition for beta thalassemia. Ann N Y Acad Sci. 2023.
Parsamanesh N, Kooshkaki O, Siami H, Santos RD, Jamialahmadi T, Sahebkar A. Gene and cell therapy approaches for familial hypercholesterolemia: An update. Drug Discov Today. 2022:103470.
Maeda A, Mandai M, Takahashi M. Gene and Induced Pluripotent Stem Cell Therapy for Retinal Diseases. Annu Rev Genomics Hum Genet. 2019.
Oh J, You Y, Yun Y, Lee HLan, Yoon DHeum, Lee M, Ha Y. A Gene and Neural Stem Cell Therapy Platform Based on Neuronal Cell Type-Inducible Gene Overexpression. Yonsei Med J. 2015;56(4):1036-1043.
Leppek K, Fujii K, Quade N, Susanto TTheo, Boehringer D, Lenarčič T, Xue S, Genuth NR, Ban N, Barna M. Gene- and Species-Specific Hox mRNA Translation by Ribosome Expansion Segments. Mol Cell. 2020.
Adhami M, MotieGhader H, Haghdoost AAkbar, Afshar RMalekpour, Sadeghi B. Gene co-expression network approach for predicting prognostic microRNA biomarkers in different subtypes of breast cancer. Genomics. 2019.
Lodato S, Molyneaux BJ, Zuccaro E, Goff LA, Chen H-H, Yuan W, Meleski A, Takahashi E, Mahony S, Rinn JL, et al. Gene co-regulation by Fezf2 selects neurotransmitter identity and connectivity of corticospinal neurons. Nat Neurosci. 2014.
Hasegawa M, Miki K, Kawamura T, Sasozaki ITakei, Higashiyama Y, Tsuchida M, Kashino K, Taira M, Ito E, Takeda M, et al. Gene correction and overexpression of TNNI3 improve impaired relaxation in engineered heart tissue model of pediatric restrictive cardiomyopathy. Dev Growth Differ. 2024.
Levesque S, Bauer DE. Gene correction for sickle cell disease hits its prime. Nat Biomed Eng. 2023;7(5):605-606.
Zhang X, Zhang D, Thompson JA, Chen S-C, Huang Z, Jennings L, McLaren TL, Lamey TM, De Roach JN, Chen FK, et al. Gene correction of the CLN3 c.175G>A variant in patient-derived induced pluripotent stem cells prevents pathological changes in retinal organoids. Mol Genet Genomic Med. 2021:e1601.
Kozlova EV, Bishay AE, Denys ME, Chinthirla BD, Valdez MC, Spurgin KA, Krum JM, Basappa KR, Currás-Collazo MC. Gene deletion of the PACAP/VIP receptor, VPAC2R, alters glycemic responses during metabolic and psychogenic stress in adult female mice. J Neuroendocrinol. 2023:e13354.
Fang Y, Chen X, Wt G. Gene delivery in tissue engineering and regenerative medicine. J Biomed Mater Res B Appl Biomater. 2014.
Kim T-H, Singh RK, Kang MSil, Kim J-H, Kim H-W. Gene delivery nanocarriers of bioactive glass with unique potential to load BMP2 plasmid DNA and to internalize into mesenchymal stem cells for osteogenesis and bone regeneration. Nanoscale. 2016.
Song S, Lu Y. Gene Delivery of Alpha-1-Antitrypsin Using Recombinant Adeno-Associated Virus (rAAV). Methods Mol Biol. 2018;1826:183-196.
Ramakrishna S, Dad A-BKwaku, Beloor J, Gopalappa R, Lee S-K, Kim H. Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA. Genome Res. 2014.
Havlicek S, Kohl Z, Mishra HK, Prots I, Eberhardt E, Denguir N, Wend H, Plötz S, Boyer L, Marchetto MCN, et al. Gene dosage dependent rescue of HSP neurite defects in SPG4 patients' neurons. Hum Mol Genet. 2013.
Fear VS, Forbes CA, Shaw NC, Farley KO, Mantegna JL, Htun JP, Syn G, Viola H, Szappanos HCserne, Hool L, et al. Gene editing and cardiac disease modelling for the interpretation of genetic variants of uncertain significance in congenital heart disease. Stem Cell Res Ther. 2023;14(1):345.
Alapati D, Morrisey EE. Gene Editing and Genetic Lung Disease: Basic Research Meets Therapeutic Application. Am J Respir Cell Mol Biol. 2016.
Giallongo S, Re OLo, Resnick I, Raffaele M, Vinciguerra M. Gene Editing and Human iPSCs in Cardiovascular and Metabolic Diseases. Adv Exp Med Biol. 2023;1396:275-298.
Cannon PM. Gene Editing Expands the Donor Pool for CCR5-Negative Stem Cell Transplants. Cell Stem Cell. 2019;25(6):735-736.
Ewart DT, Peterson EJ, Steer CJ. Gene editing for inflammatory disorders. Ann Rheum Dis. 2018.
Mishra P, Sivakumar A, Johnson A, Pernaci C, Warden AS, El-Hachem LRony, Hansen E, Badell-Grau RA, Khare V, Ramirez G, et al. Gene editing improves endoplasmic reticulum-mitochondrial contacts and unfolded protein response in Friedreich's ataxia iPSC-derived neurons. Front Pharmacol. 2024;15:1323491.